Melatonin: What the Science Actually Shows — And Where It Falls Short

Ask a room of poor sleepers what they have tried and melatonin comes up first, almost always. It is inexpensive, sold without a prescription in the United States, and marketed with a reassuring framing: it is a hormone your body already makes, so taking more should simply top up the tank.

That framing is where most of the disappointment begins. Melatonin is not a sedative and was never really a sleeping pill. It is a timing signal — and timing signals behave very differently from sedatives.

What melatonin actually does

The pineal gland releases melatonin as ambient light falls. The hormone does not knock you out; it tells the rest of the body that biological night has begun. Body temperature starts dropping, alertness declines, and the machinery that produces sleep is permitted to start. Light — particularly bright light in the evening — suppresses that release.

This distinction explains the pattern that frustrates so many readers. A supplement that moves the clock forward will help someone whose clock is in the wrong place. It has far less to offer someone whose clock is fine and whose sleep simply breaks apart at 3 in the morning.

Where the evidence is reasonably strong

Reviews of the literature consistently point to the same set of circadian problems, where melatonin has a defensible role:

• Jet lag, particularly on eastward travel across several time zones.
• Delayed sleep-wake phase — the classic "cannot fall asleep before 3, cannot wake before 11" pattern, most common in adolescents and young adults.
• Shift work and other schedules that force sleep into biological daytime.
• Non-24-hour rhythms in people who are totally blind and receive no light cue.

Even in these cases, the reported effects tend to be modest — the research generally describes shortening the time it takes to fall asleep by minutes rather than transforming a night.

Where it is weaker than the shelf space suggests

For general adult insomnia — and particularly for sleep-maintenance insomnia, the middle-of-the-night waking — the clinical picture is much less enthusiastic than the retail one. Professional guidelines for chronic insomnia in adults have declined to give melatonin a strong recommendation, citing weak or inconsistent evidence relative to behavioural treatment.

There is a structural reason. Standard immediate-release melatonin peaks quickly and clears quickly. By 3 AM, a dose taken at 10 PM has largely left the system. It was never a candidate for holding the second half of the night together.

Safety, side effects and the label problem

Short-term use is generally described as well tolerated in adults. The commonly reported effects are headache, next-morning grogginess, vivid dreams, and nausea. Long-term data in healthy adults is thinner than the volume of use would imply, and melatonin interacts with several medication classes, including blood thinners, immunosuppressants, diabetes medication and some blood-pressure drugs. Pregnancy, breastfeeding and paediatric use warrant a clinician's input rather than a shelf label.

There is a separate, under-discussed issue: in the United States melatonin is regulated as a dietary supplement, not a drug. Regulators do not verify potency or purity before sale, and independent analyses have repeatedly found the amount in the capsule diverging from the amount on the box. Third-party testing is the only practical protection.

Our editorial read

Melatonin is a real tool used for the wrong job most of the time. If your problem is that your clock is in the wrong place — travel, shift work, a chronically delayed phase — it is a rational, low-cost thing to discuss with a clinician, at a small dose and correct timing.

If your problem is that you fall asleep fine and then come apart at 3 AM, the evidence gives you little reason to expect much, and the higher doses on offer are more likely to buy you grogginess than continuity. That gap is precisely what sent us into a longer investigation of what else people are reaching for.